Molecular Genetics Augment Cytopathologic Evaluation and Surgical Planning of Pediatric Thyroid Nodules

jpedsurg.org

Molecular genetic testing in conjunction with cytopathology may improve prediction of malignancy in thyroid nodules, particularly those with indeterminate cytology (Bethesda III/IV). Though now commonplace in adults, pediatric data are limited. This study examines molecular genetics of pediatric nodules with correlation to cytologic and histologic classification at time of surgery and the distribution of mutations.

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Jan 2024 · 1 min read

In brief

This study evaluates how molecular genetic testing combined with cytopathology improves malignancy prediction in pediatric thyroid nodules, especially those with indeterminate Bethesda III/IV cytology. The research addresses a gap in pediatric data by examining mutation patterns and their correlation with surgical outcomes, potentially refining preoperative risk stratification in children.

Molecular genetic testing combined with cytopathology improves malignancy prediction in pediatric thyroid nodules with indeterminate cytology.
Pediatric data on molecular genetics for thyroid nodules remain limited compared to extensive adult literature.
Genetic testing is particularly valuable for Bethesda III/IV nodules where cytology alone is inconclusive.
Molecular profiling can guide surgical planning by clarifying malignancy risk preoperatively in children.
Understanding mutation distribution in pediatric thyroid nodules differs from adult patterns and requires specific study.

Written by the GCMD Library team from the article.

Read it at the source ↗